Vancouver???s Zymeworks to Hire an Additional 45 Employees by the End of 2017

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-zymeworks.jpg" NAME"Vancouvers Zymeworks to Hire an Additional 45 Employees by the End of 2017" ALT"Vancouvers Zymeworks to Hire an Additional 45 Employees by the End of 2017"May 31, 2017By…

Continue ReadingVancouver???s Zymeworks to Hire an Additional 45 Employees by the End of 2017

CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing" ALT"CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended…

Continue ReadingCRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing

Investors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-novartis.jpg" NAME"Investors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets" ALT"Investors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets"May 30, 2017By Mark Terry,…

Continue ReadingInvestors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets